Duffy Null–Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility.

This cross-sectional study examines absolute neutrophil count–related racial and ethnic disparities in cancer clinical trial eligibility using Duffy null status.

Bibliographic Details
Published in:JAMA Oncology Vol. 11; no. 12; pp. 1540 - 1543
Main Authors: Merz, Lauren E., Wang, Yating, Cronin, Angel, Sharon, Elad, Walsh, Thomas P., Hibbs, Stephen P., Lathan, Christopher S., Hantel, Andrew
Format: letter research tables/charts Journal Article
Published: American Medical Association Dec2025
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190379536&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190379536
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23742437
        I6NW
      jtl: JAMA Oncology
      issn: 23742437
      maglogo: N
    pubinfo:
      dt: Dec2025
      vid: 11
      iid: 12
      pid: 30
      pub: American Medical Association
      place: Chicago, Illinois
    artinfo:
      ui:
        190379536
        190379536
        190379536
        10.1001/jamaoncol.2025.3869
        190379536
      ppf: 1540
      ppct: 3
      formats:
      tig:
        atl: Duffy Null–Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility.
      aug:
        au:
          Merz, Lauren E.
          Wang, Yating
          Cronin, Angel
          Sharon, Elad
          Walsh, Thomas P.
          Hibbs, Stephen P.
          Lathan, Christopher S.
          Hantel, Andrew
        affil: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
      sug:
        subj:
          Neutrophils
          Genetic Variation
          Leukocyte Count
          Reference Values
          Cancer Patients
          Clinical Trials
          Eligibility Determination
          Research Subject Recruitment
          Race Factors
          Human
          United States
          Colorectal Neoplasms Drug Therapy
          Breast Neoplasms Drug Therapy
          Prostatic Neoplasms Drug Therapy
          Lung Neoplasms Drug Therapy
          ROC Curve
          Predictive Value of Tests
          Fisher's Exact Test
          Chi Square Test
          Pearson's Correlation Coefficient
          Descriptive Statistics
          Data Analysis Software
          African Americans
          White Persons
          Phenotype
      ab: This cross-sectional study examines absolute neutrophil count–related racial and ethnic disparities in cancer clinical trial eligibility using Duffy null status.
      pubtype: Academic Journal
      doctype:
        letter
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N